• syros gets a "win" at last | apexonco - clinical trials news and analysis Oncology Pipeline Fri, 26 Sep 2025 07:32:06 GMT
• Myelodysplastic Syndrome Pipeline Analysis, 2025 by DelveInsight | Novartis, Syros Pharmaceuticals, Curis, Ryvu Therapeutics, Chia... Barchart.com Mon, 01 Sep 2025 07:00:00 GMT
• rege nephro buys tamibarotene-related assets from syros pharmaceuticals MSN Sat, 30 Aug 2025 19:57:50 GMT
• myelodysplastic syndrome pipeline analysis, 2025 by delveinsight | novartis, syros pharmaceuticals, curis, ryvu therapeutics, chia... Barchart.com Sat, 30 Aug 2025 00:52:00 GMT
• rege nephro buys tamibarotene-related assets from syros pharmaceuticals MSN Fri, 29 Aug 2025 19:03:59 GMT
• myelodysplastic syndrome clinical trials, companies, therapeutic assessment, therapies, treatment algorithm, pipeline analysis | n... Barchart.com Mon, 28 Jul 2025 21:34:06 GMT
• analysts set syros pharmaceuticals, inc. (nasdaq:syrs) target price at $3.33 Defense World Sat, 26 Jul 2025 07:00:00 GMT
• myelodysplastic syndrome clinical trials 2025: ema, pdma, fda openPR.com Mon, 21 Jul 2025 16:26:00 GMT
• quetzal therapeutics debuts with expert leadership, high-impact pipeline and $50 million of committed capital The Manila Times Thu, 17 Jul 2025 07:00:00 GMT
• Quetzal Therapeutics Debuts with Expert Leadership, High-Impact Pipeline and $50 Million of Committed Capital GlobeNewswire Wed, 16 Jul 2025 07:00:00 GMT
• myelodysplastic syndrome pipeline insight 2025: spotlighting openPR.com Mon, 14 Jul 2025 18:58:00 GMT
• bronstein, gewirtz and grossman, llc encourages syros pharmaceuticals, inc. (syrs) stockholders to inquire about securities invest... ACCESS Newswire Thu, 03 Jul 2025 16:11:03 GMT
• watch: policy direction—where are we now? Life Sciences Intellectual Property Review Mon, 30 Jun 2025 07:00:00 GMT
• syrs news today | why did syros pharmaceuticals stock go up today? MarketBeat Sun, 29 Jun 2025 07:00:00 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) receives consensus rating of “hold” from brokerages Defense World Thu, 26 Jun 2025 07:00:00 GMT
• levi & korsinsky reminds syros pharmaceuticals investors of the ongoing investigation into potential violations of securities laws... ACCESS Newswire Sat, 07 Jun 2025 21:27:43 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) receives consensus rating of “hold” from analysts Defense World Sun, 01 Jun 2025 07:52:42 GMT
• SYROS PHARMACEUTICALS Earnings Preview: Recent $SYRS Insider Trading, Hedge Fund Activity, and More Nasdaq Fri, 30 May 2025 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) now covered by stocknews.com Defense World Fri, 16 May 2025 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) coverage initiated by analysts at stocknews.com Defense World Thu, 08 May 2025 10:39:08 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) receives consensus recommendation of “hold” from analysts Defense World Wed, 07 May 2025 07:00:00 GMT
• stocknews.com begins coverage on syros pharmaceuticals (nasdaq:syrs) Defense World Fri, 02 May 2025 09:04:36 GMT
• syrs alert: levi & korsinsky reminds investors of an investigation involving possible securities fraud violations by syros pharmac... ACCESS Newswire Sun, 27 Apr 2025 06:11:44 GMT
• shareholders that lost money on syros pharmaceuticals, inc.(syrs) should contact levi & korsinsky about securities fraud investiga... ACCESS Newswire Sun, 27 Apr 2025 03:24:51 GMT
• syrs alert- levi & korsinsky has commenced an investigation on behalf of syros pharmaceuticals, inc. shareholders who lost money ACCESS Newswire Sat, 26 Apr 2025 04:03:54 GMT
• rege nephro buys tamibarotene-related assets from syros pharmaceuticals MSN Wed, 23 Apr 2025 14:36:00 GMT
• stocknews.com initiates coverage on syros pharmaceuticals (nasdaq:syrs) Defense World Tue, 22 Apr 2025 07:00:00 GMT
• rege nephro buys tamibarotene-related assets from syros pharmaceuticals MSN Wed, 16 Apr 2025 01:58:18 GMT
• rege nephro buys tamibarotene-related assets from syros pharmaceuticals MSN Tue, 15 Apr 2025 11:11:05 GMT
• Rege Nephro Acquires Tamibarotene-Related Assets from Syros Pharmaceuticals for U.S. Clinical Trials PR Newswire Tue, 15 Apr 2025 07:00:00 GMT
• major kidney disease drug acquisition: rege nephro takes over syros' phase 2 asset Stock Titan Tue, 15 Apr 2025 07:00:00 GMT
• syros pharmaceuticals sells tamibarotene assets to rege nephro TipRanks Tue, 15 Apr 2025 07:00:00 GMT
• rege nephro acquires key assets from syros pharmaceuticals (syrs) | syrs stock news GuruFocus Tue, 15 Apr 2025 07:00:00 GMT
• rege nephro acquires assets from syros pharmaceuticals (syrs) GuruFocus Tue, 15 Apr 2025 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) coverage initiated at stocknews.com Defense World Mon, 14 Apr 2025 07:00:00 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) given average recommendation of “hold” by brokerages Defense World Sat, 12 Apr 2025 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) coverage initiated by analysts at stocknews.com Defense World Sun, 06 Apr 2025 07:00:00 GMT
• stocknews.com begins coverage on syros pharmaceuticals (nasdaq:syrs) The AM Reporter Sun, 30 Mar 2025 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) coverage initiated at stocknews.com Defense World Sat, 29 Mar 2025 07:00:00 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) short interest up 345.9% in march Defense World Thu, 27 Mar 2025 07:00:00 GMT
• syrs alert- levi & korsinsky has commenced an investigation on behalf of syros pharmaceuticals, inc. shareholders who lost money ACCESS Newswire Tue, 25 Mar 2025 09:07:34 GMT
• study unravels mystery of cancer-fueling enzyme, which could lead to new therapies Phys.org Tue, 25 Mar 2025 07:00:00 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) receives $3.33 average pt from brokerages Defense World Fri, 21 Mar 2025 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) now covered by stocknews.com Defense World Fri, 21 Mar 2025 06:39:37 GMT
• syros pharmaceuticals (syrs) to release earnings on wednesday Defense World Wed, 19 Mar 2025 07:00:00 GMT
• 12 health care stocks moving in tuesday's pre-market session Benzinga Tue, 18 Mar 2025 07:00:00 GMT
• analyze syros pharmaceuticals inc (nasdaq: syrs) before investing. stocksregister.com Mon, 17 Mar 2025 12:34:44 GMT
• syros pharmaceuticals (nasdaq:syrs) now covered by stocknews.com Defense World Thu, 13 Mar 2025 12:02:16 GMT
• finance watch: sutro halves workforce, cuts lead adc and ceo moves on insights.citeline.com Thu, 13 Mar 2025 07:00:00 GMT
• 12 health care stocks moving in wednesday's after-market session Benzinga Thu, 13 Mar 2025 07:00:00 GMT
• ualbany researchers unlock new capabilities in dna nanostructure self-assembly EurekAlert! Wed, 12 Mar 2025 07:00:00 GMT
• 12 health care stocks moving in wednesday's after-market session Benzinga Wed, 12 Mar 2025 07:00:00 GMT
• 12 health care stocks moving in wednesday's intraday session Benzinga Wed, 12 Mar 2025 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) coverage initiated at stocknews.com Defense World Wed, 05 Mar 2025 08:00:00 GMT
• Syros Pharmaceuticals settles debt with Oxford Finance Investing.com Tue, 04 Mar 2025 08:00:00 GMT
• Hello BridgeBio, farewell Syros and Achilles | ApexOnco - Clinical Trials news and analysis Oncology Pipeline Mon, 03 Mar 2025 08:00:00 GMT
• syros pharmaceuticals, inc. announces management changes -february 28, 2025 at 04:15 pm est Marketscreener.com Sat, 01 Mar 2025 11:57:35 GMT
• Failed Clinical Trial Forces Syros Pharmaceuticals Into Delisting and Wind-Down Operations Stock Titan Fri, 28 Feb 2025 08:00:00 GMT
• Syros Pharmaceuticals Delists from Nasdaq Amid Restructuring TipRanks Fri, 28 Feb 2025 08:00:00 GMT
• syros announces voluntary delisting from nasdaq and sec deregistration Business Wire Fri, 28 Feb 2025 08:00:00 GMT
• syros pharmaceuticals voluntarily delists from nasdaq, deregisters common stock TipRanks Fri, 28 Feb 2025 08:00:00 GMT
• syros pharmaceuticals to delist from nasdaq, deregister common shares -february 28, 2025 at 04:41 pm est Marketscreener.com Fri, 28 Feb 2025 08:00:00 GMT
• syros pharmaceuticals stock hits 52-week low at $0.18 amid steep decline MSN Thu, 27 Feb 2025 04:20:20 GMT
• syros pharmaceuticals (nasdaq:syrs) now covered by stocknews.com Armenian Reporter Wed, 26 Feb 2025 08:00:00 GMT
• syros pharmaceuticals stock plunges to 52-week low of $0.16 by investing.com Investing.com Australia Wed, 26 Feb 2025 08:00:00 GMT
• syros pharmaceuticals, inc. (syrs) investigation: bronstein, gewirtz and grossman, llc encourages shareholders to seek compensatio... ACCESS Newswire Wed, 26 Feb 2025 06:17:09 GMT
• Syros Pharmaceuticals stock plunges to 52-week low of $0.16 Investing.com Tue, 25 Feb 2025 08:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) now covered by stocknews.com Defense World Tue, 25 Feb 2025 07:36:51 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) receives $3.33 average price target from analysts Defense World Mon, 24 Feb 2025 08:00:00 GMT
• what did we find about insider trading at syros pharmaceuticals inc (nasdaq: syrs)? Stocks Register Wed, 19 Feb 2025 08:00:00 GMT
• stocknews.com begins coverage on syros pharmaceuticals (nasdaq:syrs) Defense World Mon, 17 Feb 2025 08:00:00 GMT
• shareholders that lost money on syros pharmaceuticals, inc.(syrs) should contact levi & korsinsky about securities fraud investiga... ACCESS Newswire Wed, 12 Feb 2025 10:08:39 GMT
• stocknews.com begins coverage on syros pharmaceuticals (nasdaq:syrs) Defense World Tue, 11 Feb 2025 08:00:00 GMT
• syros pharmaceuticals inc’s market journey: closing weak at 0.17, down -3.99 The Dwinnex Mon, 10 Feb 2025 15:21:17 GMT
• syros pharmaceuticals inc (nasdaq: syrs) now carries a 12-month price target of $5. Marketing Sentinel Sat, 08 Feb 2025 18:00:47 GMT
• bronstein, gewirtz and grossman, llc encourages syros pharmaceuticals, inc. (syrs) investors to inquire about securities investiga... ACCESS Newswire Sat, 08 Feb 2025 03:10:38 GMT
• syros pharmaceuticals inc [nasdaq: syrs] sees increase in stock value Knox Daily Fri, 07 Feb 2025 19:27:36 GMT
• check out syros pharmaceuticals inc (syrs)’s trade data rather than the analysts’ views SETE News Thu, 06 Feb 2025 15:01:48 GMT
• syros pharmaceuticals inc (syrs) stock price and analyst predictions The News Heater Wed, 05 Feb 2025 20:11:53 GMT
• h.c. wainwright upgrades syros pharmaceuticals inc (syrs) to a buy from a neutral Knox Daily Tue, 04 Feb 2025 15:04:36 GMT
• ratio examination: syros pharmaceuticals inc (syrs)’s price-to-cash and price-to-free cash flow The Dwinnex Mon, 03 Feb 2025 17:19:44 GMT
• syros pharmaceuticals (nasdaq:syrs) now covered by stocknews.com Defense World Sat, 01 Feb 2025 08:00:00 GMT
• syros pharmaceuticals stock hits 52-week low at $0.18 amid steep decline MSN Thu, 30 Jan 2025 18:31:05 GMT
• analysts set syros pharmaceuticals, inc. (nasdaq:syrs) price target at $3.33 Defense World Thu, 30 Jan 2025 06:14:33 GMT
• syros pharmaceuticals stock hits 52-week low at $0.18 amid steep decline Investing.com Canada Wed, 29 Jan 2025 08:00:00 GMT
• fulcrum therapeutics (nasdaq:fulc) versus syros pharmaceuticals (nasdaq:syrs) financial analysis Defense World Tue, 28 Jan 2025 08:00:00 GMT
• syros pharmaceuticals inc (nasdaq: syrs) fell -2280.95%, predicting what to expect in the near future Marketing Sentinel Sat, 25 Jan 2025 08:00:00 GMT
• syrs news today | why did syros pharmaceuticals stock go down today? MarketBeat Fri, 24 Jan 2025 22:07:30 GMT
• syros pharmaceuticals (syrs) stock price, news & analysis MarketBeat Fri, 24 Jan 2025 22:07:30 GMT
• syros pharmaceuticals (nasdaq:syrs) now covered by analysts at stocknews.com Defense World Fri, 24 Jan 2025 07:16:05 GMT
• syros pharmaceuticals (nasdaq:syrs) earns sell rating from analysts at stocknews.com Defense World Thu, 16 Jan 2025 08:00:00 GMT
• analysts’ revisions show improving sentiment for syros pharmaceuticals inc (nasdaq: syrs) Stocks Register Wed, 15 Jan 2025 12:32:08 GMT
• syros pharmaceuticals (nasdaq: syrs) receives notice of listing non-complianceon january 6, 2025, syros pharmaceuticals, inc. rece... Defense World Thu, 09 Jan 2025 08:00:00 GMT
• stocknews.com initiates coverage on syros pharmaceuticals (nasdaq:syrs) Defense World Wed, 08 Jan 2025 08:00:00 GMT
• brokerages set syros pharmaceuticals, inc. (nasdaq:syrs) price target at $3.33 Defense World Sun, 05 Jan 2025 06:27:44 GMT
• stocknews.com begins coverage on syros pharmaceuticals (nasdaq:syrs) Defense World Tue, 31 Dec 2024 08:00:00 GMT
• november's phase iii successes; syros, cassava tumble on misses BioWorld Online Mon, 30 Dec 2024 08:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) coverage initiated by analysts at stocknews.com Defense World Mon, 23 Dec 2024 08:00:00 GMT
• syros pharmaceuticals' swot analysis: stock faces challenges after trial setback Investing.com India Sun, 15 Dec 2024 09:18:18 GMT
• syros pharmaceuticals (nasdaq:syrs) earns sell rating from analysts at stocknews.com Defense World Sun, 15 Dec 2024 08:00:00 GMT
• syros pharmaceuticals' swot analysis: stock faces challenges after trial setback Investing.com Sat, 14 Dec 2024 08:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) coverage initiated by analysts at stocknews.com Defense World Sat, 07 Dec 2024 08:00:00 GMT
• shareholder alert: pomerantz law firm investigates claims on behalf of investors of syros pharmaceuticals, inc. - syrs The Eastern Progress Online Sat, 07 Dec 2024 00:35:37 GMT
• nancy simonian sells shares in syros pharmaceuticals for $10,016 by investing.com Investing.com Australia Thu, 05 Dec 2024 04:35:31 GMT
• nancy simonian sells shares in syros pharmaceuticals for $10,016 Investing.com Wed, 04 Dec 2024 08:00:00 GMT
• stocknews.com begins coverage on syros pharmaceuticals (nasdaq:syrs) Defense World Sun, 01 Dec 2024 08:00:00 GMT
• syros pharmaceuticals (lts:0lc7) enterprise value : $8.13 mil (as of jan. 03, 2025) GuruFocus.com Sat, 30 Nov 2024 17:16:19 GMT
• syros pharmaceuticals (nasdaq:syrs) now covered by stocknews.com Defense World Mon, 25 Nov 2024 08:00:00 GMT
• syrs (syros pharmaceuticals) 9-day rsi : 26.16 (as of nov. 24, 2024) GuruFocus.com Sun, 24 Nov 2024 07:19:57 GMT
• syros pharmaceuticals chief development officer sells shares for $7,949 Investing.com India Fri, 22 Nov 2024 05:02:28 GMT
• syros downgraded to market perform from outperform at jmp securities MSN Thu, 21 Nov 2024 15:57:28 GMT
• syros pharmaceuticals chief legal officer sells $10,320 in stock Investing.com India Thu, 21 Nov 2024 08:00:00 GMT
• syros pharmaceuticals chief medical officer sells shares for $2,382 Investing.com India Thu, 21 Nov 2024 08:00:00 GMT
• syros pharmaceuticals ceo chee conley sells shares worth $26,932 Investing.com India Thu, 21 Nov 2024 08:00:00 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) q3 2024 earnings call transcript MSN Thu, 21 Nov 2024 02:14:13 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) q3 2024 earnings call transcript MSN Wed, 20 Nov 2024 18:16:29 GMT
• syros downgraded to market perform from outperform at jmp securities MSN Wed, 20 Nov 2024 13:49:14 GMT
• syros stock plunges as lead cancer study fails to meet primary goal MSN Wed, 20 Nov 2024 12:12:46 GMT
• Syros Pharmaceuticals CEO Chee Conley sells shares worth $26,932 Investing.com Wed, 20 Nov 2024 08:00:00 GMT
• syros pharmaceuticals chief legal officer sells $10,320 in stock Investing.com Wed, 20 Nov 2024 08:00:00 GMT
• syros pharmaceuticals chief development officer sells shares for $7,949 Investing.com Wed, 20 Nov 2024 08:00:00 GMT
• syros pharmaceuticals chief medical officer sells shares for $2,382 Investing.com Wed, 20 Nov 2024 08:00:00 GMT
• Syros Pharmaceuticals Faces Financial Struggles Amid Key Challenges Nasdaq Mon, 18 Nov 2024 08:00:00 GMT
• Trial for Patients With High-Risk MDS Misses Goal, Discontinues Study Cure Today Mon, 18 Nov 2024 08:00:00 GMT
• tamibarotene fails to meet primary endpoint in myelodysplastic syndrome trial Hematology Advisor Mon, 18 Nov 2024 08:00:00 GMT
• syros pharmaceuticals hits record low on qiagen deal termination and leadership changes XM Mon, 18 Nov 2024 08:00:00 GMT
• what is hc wainwright’s forecast for syrs q1 earnings? Defense World Sun, 17 Nov 2024 07:49:10 GMT
• avidity partners management lp's strategic acquisition in syros pharmaceuticals inc GuruFocus Fri, 15 Nov 2024 08:00:00 GMT
• blue owl capital holdings lp increases stake in syros pharmaceuticals inc GuruFocus.com Fri, 15 Nov 2024 08:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) earns hold rating from td cowen Defense World Fri, 15 Nov 2024 07:45:19 GMT
• syros pharmaceuticals (nasdaq:syrs) earns neutral rating from hc wainwright Defense World Fri, 15 Nov 2024 07:45:19 GMT
• syros shares rating downgraded after failed select-mds-1 study by investing.com Investing.com Nigeria Thu, 14 Nov 2024 09:04:25 GMT
• jmp securities cuts syros pharma stock rating following unsuccessful trial by investing.com Investing.com Australia Thu, 14 Nov 2024 08:01:08 GMT
• Syros Stock Plunges as Lead Cancer Study Fails to Meet Primary Goal Yahoo Finance Thu, 14 Nov 2024 08:00:00 GMT
• petri dish: syros stock plunges 85% on trial fail; new ceos at flagship spinouts The Business Journals Thu, 14 Nov 2024 08:00:00 GMT
• syros pharmaceuticals downgraded to neutral from buy at h.c. wainwright Yahoo Finance Thu, 14 Nov 2024 08:00:00 GMT
• syros pharmaceuticals' swot analysis: stock faces headwinds after trial setback Investing.com Canada Thu, 14 Nov 2024 00:44:07 GMT
• syros pharmaceuticals (nasdaq:syrs) receives hold rating from brookline capital management MarketBeat Wed, 13 Nov 2024 14:46:48 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) given average recommendation of "buy" by brokerages MarketBeat Wed, 13 Nov 2024 14:16:43 GMT
• syros pharmaceuticals (nasdaq:syrs) earns "market perform" rating from jmp securities MarketBeat Wed, 13 Nov 2024 14:00:50 GMT
• syros pharmaceuticals (nasdaq:syrs) earns "neutral" rating from hc wainwright MarketBeat Wed, 13 Nov 2024 13:57:32 GMT
• td cowen reiterates "hold" rating for syros pharmaceuticals (nasdaq:syrs) MarketBeat Wed, 13 Nov 2024 13:40:30 GMT
• another study failure puts brakes on syros’ tamibarotene in blood cancers FirstWord Pharma Wed, 13 Nov 2024 09:03:46 GMT
• Syros flunks phase 3 blood cancer trial, triggering loan default and share-price plunge Fierce Biotech Wed, 13 Nov 2024 08:00:00 GMT
• Syros Crashes Over 90% on Late-Stage MDS Fail, Loan Default BioSpace Wed, 13 Nov 2024 08:00:00 GMT
• Syros stock craters after lead cancer therapy flops in Phase III trial Clinical Trials Arena Wed, 13 Nov 2024 08:00:00 GMT
• The end looms for Syros | ApexOnco - Clinical Trials news and analysis Oncology Pipeline Wed, 13 Nov 2024 08:00:00 GMT
• Another study failure puts brakes on Syros' tamibarotene in blood cancers FirstWord Pharma Wed, 13 Nov 2024 08:00:00 GMT
• syros shares rating downgraded after failed select-mds-1 study Investing.com Wed, 13 Nov 2024 08:00:00 GMT
• td cowen downgrades syros pharma stock to hold on trial failure Investing.com Wed, 13 Nov 2024 08:00:00 GMT
• syros pharmaceuticals stock sinks as pivotal blood cancer trial flunks, triggers loan default Benzinga Wed, 13 Nov 2024 08:00:00 GMT
• syros pharmaceuticals downgraded to neutral from buy at h.c. wainwright TipRanks Wed, 13 Nov 2024 08:00:00 GMT
• syros’s hopes dashed as tamibarotene flunks phase iii mds trial insights.citeline.com Wed, 13 Nov 2024 08:00:00 GMT
• no rara, syros trouble: mds phase iii sinks tamibarotene BioWorld MedTech Wed, 13 Nov 2024 08:00:00 GMT
• u.s. stock market: syros pharmaceuticals(−86.21%), glucotrack(−77.70%) and others among the most volatile stocks during mid day tr... Business Upturn Wed, 13 Nov 2024 08:00:00 GMT
• u.s. stock market: syros pharmaceuticals surges by 680.00% while spirit airlines rises by 184.96% in early trading Business Upturn Wed, 13 Nov 2024 08:00:00 GMT
• us stocks mixed; inflation rate increases in october - btc digital (nasdaq:btct) Benzinga Wed, 13 Nov 2024 08:00:00 GMT
• analysts set syros pharmaceuticals, inc. (nasdaq:syrs) target price at $5.00 MarketBeat Wed, 13 Nov 2024 08:00:00 GMT
• jmp securities cuts syros pharma stock rating following unsuccessful trial Investing.com Wed, 13 Nov 2024 08:00:00 GMT
• jmp securities cuts syros pharma stock to market perform Investing.com Wed, 13 Nov 2024 08:00:00 GMT
• syros pharmaceuticals shares plummet premarket after study failure MarketWatch Wed, 13 Nov 2024 08:00:00 GMT
• tamibarotene plus azacitidine fails to improve cr rates in high-risk, rara+ mds OncLive Wed, 13 Nov 2024 08:00:00 GMT
• syros pharmaceuticals' swot analysis: stock faces headwinds after trial setback Investing.com Wed, 13 Nov 2024 08:00:00 GMT
• syros downgraded to market perform from outperform at jmp securities TipRanks Wed, 13 Nov 2024 08:00:00 GMT
• syros pharmaceuticals' (syrs) "hold" rating reaffirmed at td cowen MarketBeat Wed, 13 Nov 2024 08:00:00 GMT
• syros pharmaceuticals downgraded to hold from buy at td cowen TipRanks Wed, 13 Nov 2024 08:00:00 GMT
• syros pharmaceuticals' (syrs) hold rating reiterated at brookline capital management MarketBeat Wed, 13 Nov 2024 08:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) earns neutral rating from hc wainwright MarketBeat Wed, 13 Nov 2024 08:00:00 GMT
• jmp securities reiterates market perform rating for syros pharmaceuticals (nasdaq:syrs) MarketBeat Wed, 13 Nov 2024 08:00:00 GMT
• syros pharmaceuticals says select-mds-1 trial did not meet primary endpoint TipRanks Wed, 13 Nov 2024 00:50:28 GMT
• syros stock dives 92% on failed phase 3 study, possible loan default (update) MSN Tue, 12 Nov 2024 23:13:33 GMT
• syros pharma stock alert: phase 3 trial fails, loan default triggered | syrs stock news Stock Titan Tue, 12 Nov 2024 08:00:00 GMT
• syros pharmaceuticals trial fails to meet primary goal Investing.com Tue, 12 Nov 2024 08:00:00 GMT
• syros announces topline data from select-mds-1 phase 3 trial of tamibarotene in higher-risk myelodysplastic syndrome with rara gen... Business Wire Tue, 12 Nov 2024 08:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) rating lowered to sell at stocknews.com MarketBeat Tue, 05 Nov 2024 04:41:32 GMT
• syrs (syros pharmaceuticals) total inventories : $0.00 mil (as of sep. 2024) GuruFocus.com Tue, 05 Nov 2024 03:46:54 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) q3 2024 earnings call transcript MSN Tue, 05 Nov 2024 01:58:48 GMT
• syros pharmaceuticals, inc. announced that it expects to receive $10 million in funding from incyte corporation Marketscreener.com Mon, 04 Nov 2024 12:50:10 GMT
• syros pharmaceuticals (nasdaq:syrs) rating lowered to sell at stocknews.com MarketBeat Mon, 04 Nov 2024 08:00:00 GMT
• incyte corporation and yros pharmaceuticals announce global target discovery and validation collaboration focused on myeloprolifer... Marketscreener.com Sun, 03 Nov 2024 20:15:47 GMT
• syrsw (syros pharmaceuticals) 5-year dividend growth rate : 0.00% (as of jun. 2024) GuruFocus.com Sat, 02 Nov 2024 14:36:54 GMT
• syros pharmaceuticals third quarter 2024 earnings: us$0.16 loss per share (vs us$1.43 loss in 3q 2023) Yahoo Finance Sat, 02 Nov 2024 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) announces earnings results MarketBeat Fri, 01 Nov 2024 18:17:44 GMT
• syros pharmaceuticals (nasdaq:syrs) earns buy rating from hc wainwright MarketBeat Fri, 01 Nov 2024 12:45:54 GMT
• syros pharmaceuticals inc (syrs) q3 2024 earnings call highlights: strategic focus on ... Yahoo Finance Fri, 01 Nov 2024 07:00:00 GMT
• earnings call: syros pharmaceuticals outlines tamibarotene progress Investing.com Fri, 01 Nov 2024 07:00:00 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) q3 2024 earnings call transcript Insider Monkey Fri, 01 Nov 2024 07:00:00 GMT
• hc wainwright reaffirms "buy" rating for syros pharmaceuticals (nasdaq:syrs) MarketBeat Fri, 01 Nov 2024 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) issues quarterly earnings results MarketBeat Fri, 01 Nov 2024 07:00:00 GMT
• syros pharma earnings beat by $0.52, revenue topped estimates Investing.com India Fri, 01 Nov 2024 04:54:24 GMT
• earnings call: syros pharmaceuticals outlines tamibarotene progress Investing.com India Thu, 31 Oct 2024 18:22:30 GMT
• syros pharma earnings beat by $0.52, revenue topped estimates Investing.com Thu, 31 Oct 2024 15:39:47 GMT
• q3 2024 syros pharmaceuticals inc earnings call transcript GuruFocus.com Thu, 31 Oct 2024 12:30:00 GMT
• syros pharmaceuticals, inc. reports earnings results for the third quarter and nine months ended september 30, 2024 Marketscreener.com Thu, 31 Oct 2024 10:50:00 GMT
• Syros Reports Third Quarter 2024 Financial Results and Provides a Business Update Business Wire Thu, 31 Oct 2024 07:00:00 GMT
• syros pharmaceuticals, inc. (nasdaq:syrs) q3 2024 earnings call transcript MSN Thu, 31 Oct 2024 07:00:00 GMT
• syros pharmaceuticals reports q3 eps (16c), consensus (72c) TipRanks Thu, 31 Oct 2024 07:00:00 GMT
• syros pharmaceuticals (syrs) loses -70.55% in 4 weeks, here's why a trend reversal may be around the corner MSN Sat, 26 Oct 2024 03:26:40 GMT
• syros pharmaceuticals (syrs) set to announce earnings on thursday MarketBeat Fri, 25 Oct 2024 07:00:00 GMT
• syros pharmaceuticals' swot analysis: stock outlook amid clinical setbacks Investing.com India Fri, 25 Oct 2024 06:38:04 GMT
• syros to report third quarter 2024 financial results on thursday, october 31, 2024 Business Wire Thu, 24 Oct 2024 07:00:00 GMT
• syros pharmaceuticals' swot analysis: stock outlook amid clinical setbacks Investing.com Thu, 24 Oct 2024 07:00:00 GMT
• piper sandler reaffirms overweight rating and $5 pt on syros pharmaceuticals stock Investing.com UK Wed, 23 Oct 2024 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) upgraded by stocknews.com to "hold" MarketBeat Tue, 15 Oct 2024 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) rating increased to hold at stocknews.com MarketBeat Tue, 15 Oct 2024 06:40:10 GMT
• syros pharmaceuticals inc (syrs) q2 2024 earnings call highlights: strategic focus on ... Yahoo Finance Wed, 09 Oct 2024 07:00:00 GMT
• syros pharmaceuticals (nasdaq:syrs) downgraded by stocknews.com MarketBeat Tue, 08 Oct 2024 03:22:01 GMT
• syros pharmaceuticals (nasdaq:syrs) downgraded by stocknews.com MarketBeat Mon, 07 Oct 2024 07:00:00 GMT
• syros pharmaceuticals' swot analysis: stock faces challenges amid clinical setbacks by investing.com Investing.com South Africa Tue, 01 Oct 2024 03:10:38 GMT
• syros pharmaceuticals' swot analysis: stock faces challenges amid clinical setbacks Investing.com Mon, 30 Sep 2024 07:00:00 GMT
• cdk 7 inhibitors market is expected to showcase a significant growth by 2034 | delveinsight PR Newswire Wed, 25 Sep 2024 07:00:00 GMT
• understanding the risks of investing in syros pharmaceuticals inc. (syrs) Knox Daily Tue, 17 Sep 2024 19:28:10 GMT
• what is the investor’s view on syros pharmaceuticals inc. (syrs)? US Post News Tue, 17 Sep 2024 11:25:45 GMT
• syros pharmaceuticals chief financial officer acquires 407% more stock simplywall.st Sat, 14 Sep 2024 07:00:00 GMT
Syros Pharmaceuticals, Inc(NASDAQ:SYRS) 
Syros Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of treatments for cancer and monogenic diseases, and building a pipeline of gene control medicines. The company's lead product candidates are SY-1425, a selective retinoic acid receptor alpha agonist, which is in Ph...
Website: http://www.syros.com
Founded: 2011
Full Time Employees: 83
Sector: Healthcare
Industry: Biotechnology